Patents by Inventor Huijia Cheng

Huijia Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of triacontanol in preparation of medicaments for treatment of cancers
    Patent number: 7863337
    Abstract: Use of triacontanol in preparation of human medicaments for treatment of cancers, especially liver cancer, intestinal cancer, and lung cancer. Triacontanol can be formulated into many formulations, such as oral tablets, capsules, drop pills, sustained-released formulation, injectable solution, injectable powder, suspension, and emulsion.
    Type: Grant
    Filed: September 30, 2007
    Date of Patent: January 4, 2011
    Inventors: Xiane Fan, Renwei Zhang, Huijia Cheng
  • PREPARATIVE METHOD OF DIHYDROCUCURBITACIN F-25-O-ACETATE AND THE USE THEREOF IN THE MANUFACTURE OF MEDICAMENTS FOR TREATING CANCERS
    Publication number: 20100168451
    Abstract: A method for producing dihydrocucurbitacin F-25-0-acetate consisting of the steps as followed: percolating radix hemsleyae using acetone as solvents to obtain extract; eluting the extract in silica gel column using chloroform: methanol as eluting agent (gradient) to obtain the crude; recrystallizating the crude using methanol or ethanol to obtain di-hydrocucurbitacin F-25-O-acetate (purity:>98%). And the use of dihydrocucurbitacin F-25-O-acetate in the manufacture of medicaments for treating cancers of liver, lung, stomach, larynx, prostate and leukemia.
    Type: Application
    Filed: October 19, 2007
    Publication date: July 1, 2010
    Inventors: Xiane Fan, Renwei Zhang, Huijia Cheng
  • Use of Triacontanol in Preparation of Medicaments for Treatment of Cancers
    Publication number: 20100041924
    Abstract: Use of triacontanol in preparation of human medicaments for treatment of cancers, especially liver cancer, intestinal cancer, and lung cancer. Triacontanol can be formulated into many formulations, such as oral tablets, capsules, drop pills, sustained-released formulation, injectable solution, injectable powder, suspension, and emulsion.
    Type: Application
    Filed: September 30, 2007
    Publication date: February 18, 2010
    Inventors: Xiane Fan, Renwei Zhang, Huijia Cheng